10) Transformational Medical Technologies Initiative
Abstract
Development of Platform Technologies: Platform Technologies are standalone enabling technologies that support MCM development and when strategically aligned, provide a system of systems response capability to an adverse biological event - from the identification of an unknown pathogen to the development of an approved countermeasure ready for delivery to the Warfighter and the nation. The enabling technologies are divided into five platform areas: Pathogen Characterization, Target Identification, Countermeasure Discovery, Countermeasure Evaluation, and Bioinfomatics. Applied research efforts include the maturation of the components necessary to develop an integrated capability from pathogen identification and characterization to countermeasure delivery. Off-the-shelf technologies will be identified, evaluated, and where applicable, refined to demonstrate the ability to provide drug development capabilities.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2012
- Source ID
- 41b5a282244f4bf33c6b8a5b73aa62fe